1. Home
  2. PFAI vs MDXH Comparison

PFAI vs MDXH Comparison

Compare PFAI & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFAI

Pinnacle Food Group Limited

N/A

Current Price

$3.60

Market Cap

46.4M

ML Signal

N/A

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.44

Market Cap

41.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFAI
MDXH
Founded
2015
2003
Country
Canada
Belgium
Employees
13
N/A
Industry
Farming/Seeds/Milling
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
46.4M
41.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PFAI
MDXH
Price
$3.60
$0.44
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
1.7K
758.2K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.78
Revenue Next Year
N/A
$18.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$0.45
52 Week High
$4.93
$5.33

Technical Indicators

Market Signals
Indicator
PFAI
MDXH
Relative Strength Index (RSI) 43.57 18.95
Support Level $3.56 N/A
Resistance Level $4.07 $3.79
Average True Range (ATR) 0.10 0.05
MACD -0.02 0.04
Stochastic Oscillator 0.00 11.12

Price Performance

Historical Comparison
PFAI
MDXH

About PFAI Pinnacle Food Group Limited

Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: